What is it about?
In this article, biological mass spectrometrists and transplant surgeons work together to track allograft outcomes using high throughput, intact proteome analysis.
Featured Image
Why is it important?
This work represents a landmark foray of next-gen top-down proteomics technology as a discovery tool in translational and clinical spheres, namely transplant immunobiology.
Read the Original
This page is a summary of: Comparative top down proteomics of peripheral blood mononuclear cells from kidney transplant recipients with normal kidney biopsies or acute rejection, PROTEOMICS, July 2016, Wiley,
DOI: 10.1002/pmic.201600008.
You can read the full text:
Contributors
The following have contributed to this page